Sizzle or Gristle? Hot Stocks Are Curious Bunch
The shares with the highest 52-week returns are mostly volatile bulletin board stocks.
Corixa Shares Plunge as Investors Question Coulter's Price
Is the steep premium too much for a biotech with no products on the market? Corixa's 18% drop suggests some investors think so.
Update: Corixa to Purchase Coulter
The all-stock transaction is expected to be completed in December.
Immunomedics Falls Nearly 6% as FDA Warns Cancer Center Over Drug Tests
A cancer center the company has worked with did not notify the agency of tests, the FDA says.
Update: Immunomedics Says Drug Trials Haven't Been Halted
'No clinical trials sponsored by Immunomedics have been halted because of adverse events or deaths,' the CEO says.
Target Brings New Designer Brands to Its Stores
Target brings in a famous partner to expand designs.
Chick-fil-A Offers a New Dining Experience
Chick-fil-A is offering more variety in a new concept.
Elon Musk Has Questions About the War in Ukraine
The billionaire had proposed a controversial plan to end the Russia-Ukraine conflict, which now has lasted nearly a year.